Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccinations01:51

Vaccinations

Overview
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing adult cardiac surgical site infections and the economic impact of using multidisciplinary collaboration.

The Journal of hospital infection·2018
Same author

Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis.

Amino acids·2007
Same author

Peptidology: short amino acid modules in cell biology and immunology.

Amino acids·2006
Same author

Flow cytometry DNA content and morphobiological characteristics in chronic and neoplastic human liver disease.

The Italian journal of gastroenterology·1995
Same author

[Can alpha-interferon exacerbate a case of mixed cryoglobulinemia?].

Recenti progressi in medicina·1992
Same author

Production processes of recombinant IL-1 beta from Bacillus subtilis: comparison between intracellular and exocellular expression.

Journal of biotechnology·1991

Related Experiment Video

Updated: May 24, 2026

Detection and Isolation of Campylobacter spp. from Raw Meat
05:34

Detection and Isolation of Campylobacter spp. from Raw Meat

Published on: February 23, 2024

Developing an anti-Campylobacter jejuni vaccine.

G Lucchese1, A Pesce Delfino

  • 1Department of Biochemistry and Molecular Biology, University of Bari, Italy. guglielmo.lucchese@gmail.com

Immunopharmacology and Immunotoxicology
|March 21, 2012
PubMed
Summary

This study uses proteomics to develop a novel vaccine targeting Campylobacter jejuni

Area of Science:

  • Microbiology and Immunology
  • Proteomics
  • Vaccine Development

Background:

  • Understanding host-microbe interactions is crucial for infectious disease control.
  • Campylobacter jejuni is a major bacterial pathogen.
  • Cytolethal distending toxin (CDT) is a key virulence factor of C. jejuni.

Purpose of the Study:

  • To design a safe and effective vaccine against Campylobacter jejuni.
  • To leverage proteomics for identifying vaccine targets.
  • To ensure vaccine specificity by avoiding host protein mimicry.

Main Methods:

  • Proteomic analysis to compare microbial and host proteomes.
  • Identification of unique peptide sequences in C. jejuni CDT.
  • Rational design of vaccine candidates based on non-host-homologous peptides.

More Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
08:23

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens

Published on: March 10, 2020

Related Experiment Videos

Last Updated: May 24, 2026

Detection and Isolation of Campylobacter spp. from Raw Meat
05:34

Detection and Isolation of Campylobacter spp. from Raw Meat

Published on: February 23, 2024

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
08:23

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens

Published on: March 10, 2020

Main Results:

  • Proteomics enabled the identification of specific targets within C. jejuni CDT.
  • Novel peptide sequences were identified that are absent in the human proteome.
  • These unique peptides are proposed as candidates for a highly specific vaccine.

Conclusions:

  • Proteomics offers a powerful approach for designing targeted vaccines.
  • Vaccines based on host-absent peptides can achieve high efficacy and safety.
  • This strategy holds promise for combating C. jejuni infections.